US4097483A
(en)
*
|
1974-11-01 |
1978-06-27 |
Kyorin Pharmaceutical Co., Ltd. |
Pyrazolo 1,5-a!pyridines
|
JPS5154583A
(en)
*
|
1974-11-01 |
1976-05-13 |
Kyorin Seiyaku Kk |
Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
|
US4237300A
(en)
*
|
1975-12-09 |
1980-12-02 |
Merck & Co., Inc. |
Certain 6-substituted-2-pyridinamines
|
JPS5968553A
(ja)
*
|
1982-10-13 |
1984-04-18 |
Automob Antipollut & Saf Res Center |
燃料タンク内蔵式燃料ポンプ
|
JPS6072975U
(ja)
*
|
1983-10-26 |
1985-05-22 |
ヤンマーディーゼル株式会社 |
燃料ポンプのエア抜き装置
|
JPH0621066B2
(ja)
*
|
1984-03-14 |
1994-03-23 |
杏林製薬株式会社 |
3―イソブチリル―2―イソプロピルピラゾロ〔1,5―a〕ピリジンの徐放性医薬品組成物
|
JPS6263520A
(ja)
*
|
1985-09-14 |
1987-03-20 |
Kyorin Pharmaceut Co Ltd |
抗リウマチ剤
|
US4925849A
(en)
*
|
1987-06-15 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
Pharmaceutically useful pyrazolopyridines
|
JPH01153633A
(ja)
*
|
1987-12-10 |
1989-06-15 |
Kyorin Pharmaceut Co Ltd |
経皮吸収製剤
|
EP0355234A1
(fr)
*
|
1988-08-25 |
1990-02-28 |
Merrell Dow Pharmaceuticals Inc. |
Dérivés de la pyrazolo-pyridine avec activité antiethérosclérotique et hypecholesthérolémique
|
JPH085790B2
(ja)
*
|
1988-11-11 |
1996-01-24 |
杏林製薬株式会社 |
記憶障害改善薬
|
JPH0256853U
(fr)
*
|
1989-10-04 |
1990-04-24 |
|
|
JPH06166687A
(ja)
*
|
1990-07-18 |
1994-06-14 |
Senju Pharmaceut Co Ltd |
ピラゾロ〔1,5−a〕ピリジン化合物、その製造法および用途
|
PL200923B1
(pl)
|
1999-08-21 |
2009-02-27 |
Nycomed Gmbh |
Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
|
RS20050106A
(en)
|
2002-08-19 |
2007-11-15 |
Pfizer Products Inc., |
Combination therapy for hyperproliferative diseases
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
CA2517487A1
(fr)
|
2003-04-01 |
2004-10-14 |
Applied Research Systems Ars Holding N.V. |
Inhibiteurs de phosphodiesterases dans l'infecondite
|
CA2753318A1
(fr)
|
2003-05-30 |
2004-12-09 |
Ranbaxy Laboratories Limited |
Derives pyrroliques substitues
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
WO2005051293A2
(fr)
|
2003-11-21 |
2005-06-09 |
Combinatorx, Incorporated |
Procedes et reactifs destines au traitement de troubles inflammatoires
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
EP1948599A1
(fr)
|
2005-11-08 |
2008-07-30 |
Ranbaxy Laboratories Limited |
Procede de preparation de sel hemicalcique d acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
|
NZ568694A
(en)
|
2005-11-09 |
2011-09-30 |
Zalicus Inc |
Method, compositions, and kits for the treatment of medical conditions
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
EP2038279A2
(fr)
*
|
2006-06-06 |
2009-03-25 |
Avigen, Inc. |
Composés de pyrazolo [1,5-alpha] pyridine substituée et leurs procédés d'utilisation
|
ATE547394T1
(de)
|
2006-12-01 |
2012-03-15 |
Bristol Myers Squibb Co |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
|
PT2131841E
(pt)
|
2007-01-30 |
2012-09-24 |
Univ Colorado Regents |
Métodos para tratar a dor aguda e sub-crónica
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EA020466B1
(ru)
|
2007-06-04 |
2014-11-28 |
Синерджи Фармасьютикалз Инк. |
Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
|
US7536799B2
(en)
*
|
2007-06-07 |
2009-05-26 |
Keson Industries |
Chalk line apparatus with strategically located chalk fill opening
|
CA2692653A1
(fr)
*
|
2007-07-11 |
2009-01-15 |
Auckland Uniservices Limited |
Pyrazolo[1,5-.alpha.]pyridines et leur utilisation en cancerotherapie
|
CN101842098A
(zh)
*
|
2007-08-10 |
2010-09-22 |
基因实验室技术有限公司 |
用于治疗病毒感染的含氮的二环化学实体
|
EP2184284B1
(fr)
*
|
2007-08-15 |
2013-04-10 |
Kyorin Pharmaceutical Co., Ltd. |
Agent préventif, inhibiteur ou remède pour l'anévrisme cérébral comprenant de l'ibudilast en tant qu'ingrédient actif
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
WO2010005520A2
(fr)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
Dérivés de 2-alkyl-3-acylpyrazolo[1,5-a]pyridines
|
CA2730603C
(fr)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonistes de la guanylate cyclase utiles dans le traitement des affections gastro-intestinales, de l'inflammation gastro-intestinale, du cancer gastro-intestinal et d'autres affections
|
WO2010017047A1
(fr)
*
|
2008-08-05 |
2010-02-11 |
Merck & Co., Inc. |
Composés thérapeutiques
|
WO2010021681A2
(fr)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
CA2780683A1
(fr)
|
2009-11-13 |
2011-05-19 |
Toray Industries, Inc. |
Combinaison therapeutique ou prophylactique d'une prostaglandine i2 et d'une thiazolidine destinee au diabete
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
CA2828346C
(fr)
|
2011-03-01 |
2021-01-26 |
Synergy Pharmaceuticals Inc. |
Procede de preparation d'agonistes du guanylate cyclase c
|
ES2395801B1
(es)
|
2011-06-23 |
2014-06-06 |
María Carmen PARDINA PALLEJÀ |
"pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
|
CN102617579A
(zh)
*
|
2012-03-28 |
2012-08-01 |
黑龙江大学 |
一种异丁司特的制备方法
|
AU2014218599C1
(en)
|
2013-02-25 |
2018-09-06 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
WO2014170786A1
(fr)
|
2013-04-17 |
2014-10-23 |
Pfizer Inc. |
Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
MX2016001714A
(es)
|
2013-08-09 |
2016-10-03 |
Ardelyx Inc |
Compuestos y metodos para inhibir el transporte de fosfato.
|
WO2016055901A1
(fr)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Composés d'amide substitué
|
CN108033959A
(zh)
*
|
2018-01-29 |
2018-05-15 |
山东省药学科学院 |
一种异丁司特的化学合成方法
|
WO2020150473A2
(fr)
|
2019-01-18 |
2020-07-23 |
Dogma Therapeutics, Inc. |
Inhibiteurs de pcsk9 et leurs procédés d'utilisation
|
JP2022533251A
(ja)
|
2019-05-21 |
2022-07-21 |
アルデリックス, インコーポレイテッド |
患者において血清リン酸塩を低下させるための組み合わせ
|
CN113387947B
(zh)
*
|
2021-07-12 |
2022-07-01 |
中国科学院成都生物研究所 |
调节雌激素受体合成活性的吡唑并吡啶衍生物
|